title: Simplified maintenance therapy with abacavir/lamivudine and atazanavir after discontinuation of ritonavir.
authors.forename: Richard
authors.initials: R
authors.lastname: Elion
authors.forename: Daniel
authors.initials: D
authors.lastname: Berger
authors.forename: Gary
authors.initials: G
authors.lastname: Richmond
authors.forename: Michael
authors.initials: M
authors.lastname: Sension
authors.forename: Edwin
authors.initials: E
authors.lastname: Dejesus
authors.forename: Paul
authors.initials: P
authors.lastname: Cimoch
authors.forename: Marty
authors.initials: M
authors.lastname: St Clair
authors.forename: Linda
authors.initials: L
authors.lastname: Yau
authors.forename: Belinda
authors.initials: B
authors.lastname: Ha
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000069446:Atazanavir Sulfate; D015224:Dideoxynucleosides / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism / Q000821:virology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008077:Lipoproteins, LDL / Q000378:metabolism; D008297:Male; D054539:Medication Therapy Management; D008875:Middle Aged; D009842:Oligopeptides / Q000627:therapeutic use*; D010865:Pilot Projects; D011725:Pyridines / Q000627:therapeutic use*; D019438:Ritonavir / Q000627:therapeutic use*; D016896:Treatment Outcome; D028761:Withholding Treatment; D000099227:Abacavir
chemical_list: D019380:Anti-HIV Agents; D000069446:Atazanavir Sulfate; D015224:Dideoxynucleosides; D017320:HIV Protease Inhibitors; D019259:Lamivudine; D008077:Lipoproteins, LDL; D009842:Oligopeptides; D011725:Pyridines; D019438:Ritonavir; D000099227:Abacavir